MBHB partner Dr. Kevin Noonan is a featured presenter at the American Conference Institute’s 5th Annual Summit on Biosimilars set for June 4-6, 2014 in New York City.
Details for Dr. Noonan’s presentation are as follows:
Friday, June 6 – 2:30-3:15 p.m. ET
Case Spotlight: Momenta v. Amphastar and Bioequivalence: Understanding the Implications for the Future of Biosimilars
About American Conference Institute
A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world. Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.